NCCPF No:- 450066
Catalogue Information : |
|||||
| Candida | parapsilosis | ||||
| 450066 | |||||
Senders Details : |
|||||
| pgimer | NA | ||||
| NA | |||||
| 27-Apr-2021 | |||||
| 304 | |||||
MALDI Based Identification : |
|||||
| candida parapsilosis | 99.9 Biomereux | ||||
| 01-May-2021 | |||||
DNA Sequencing Based Identification : |
|||||
| Candida parapsilosis | ITS | ||||
| 100% | 04-Nov-2022 | ||||
| 1667553442_450066_1.pdf | 450066 | ||||
| Candida parapsilosis | |||||
ANTIFUNGAL SUSCEPTIBILITY TESTING (AFST) CLSI METHOD : |
|||||
| Yeast | none | ||||
| candida parapsilosis | |||||
| 1 | Micafungin | 2.000 | Sensitive | ||
| 2 | Amphotericin B | 2.000 | Resistant | ||
| 3 | Fluconazole | 32.000 | Resistant | ||
| 4 | Voriconazole | 0.250 | Sensitive | ||
| 5 | Itraconazole | 0.500 | Sensitive | ||
| 6 | posaconazole | 0.250 | Sensitive | ||
| 7 | Caspofungin | 2.000 | Sensitive | ||
| 8 | Anindulifungin | 2.000 | Sensitive | ||